B lymphocytes as autoantigen-presenting cells in the amplification of autoimmunity

Annals of the New York Academy of Sciences

Volumn 815, Issue , 1997, Pages 88-100

  Roth, Rita ^a   Gee, Renelle J ^a   Mamula, Mark J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD28 ANTIGEN; CYTOCHROME C; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA B7 ANTIGEN; SMALL NUCLEAR RIBONUCLEOPROTEIN; T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; B LYMPHOCYTE; CELL STIMULATION; CELL SURFACE; CONFERENCE PAPER; DIABETES MELLITUS; ETIOLOGY; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; RECEPTOR BINDING; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALIA;

EID: 0030755510     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb52047.x     Document Type: Conference Paper

References (58)

1. SCHWARTZ, R. H. 1988. Acquisition of immunologie tolerance. Cell 57: 1073-1081.
2. BRETSCHER, P. 1992. The two-signal model of lymphocyte activation twenty-one years later. Immunol. Today 13: 74-76.
3. HARDING, F. A., J. G. MCARTHUR, J. A. GROSS, D. H. RAULET & J. P. ALLISON. 1992. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356: 607-609.
4. FREEMAN, G. J., G. S. GRAY, C. D. GIMMI, D. B. LOMBARD, L-J. ZHOU, M. WHITE, J. D. FINGEROTH, J. G. GRIEBEN & L. M. NADLER. 1991. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J. Exp. Med. 174: 625-631.
5. FREEMAN, G. J., F. BORRIELLO, R. J. HODES, H. REISER, J. G. GRIBBEN, J. W. NG, J. KIM, J. GOLDBERG, K. HATHCOCK, G. LASZLO, L. A. LOMBARD, S. WANG, G. S. GRAY, L. M. NADLER & A. H. SHARPE. 1993. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin-2 production. J. Exp. Med. 178: 2185-2192.
6. LENSCHOW, D. J., G. H-T. SU, L. A. ZUCKERMAN, N. NABAVI, C. J. JELLIS, G. S. GRAY, J. MILLER & J. A. BLUESTONE. 1993. Expression and functional significance of an additional ligand for CTLA4. Proc. Natl. Acad. Sci. U.S.A. 90: 11054-11058.
7. HATHCOCK, K. S., G. LASZLO, H. B. DICKLER, J. BRADSHAW, P. LINSLEY & R. J. HODES. 1993. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Nature 362: 905-907.
8. AZUMA, M., D. ITO, H. YAGITA, K. OKUMURA, J. H. PHILLIPS, L. L. LANIER & C. SOMOZA. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366: 76-79.
9. FREEMAN, G. J., F. BORRIELLO, R. J. HODES, H. REISER, K. S. HATHCOCK, G. LASZLO, A. J. MCKNIGHT, J. KIM, L. Du, D. B. LOMBARD, G. S. GRAY, L. M. NADLER & A. H. SHARPE. 1993. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262: 907-909.
10. FREEMAN, G. J., J. G. GRIBBEN, V. A. BOUSSIOTIS, J. W. NG, V. A. RESTIVO, L. A. LOMBARD, G. S. GRAY & L. M. NADLER. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262: 909-911.
11. CHEN, C., D. A. FAHERTY, A. GAULT, S. E. CONNAUGHTON, G. D. POWERS, D. I. GODFREY & N. NABAVI. 1994. Monoclonal antibody 2D10 recognizes a novel T cell costimulatory molecule on activated murine B lymphocytes. J. Immunol. 152: 2105-2114.
12. LINSLEY, P. S., W. BRADY, L. GROSMAIRE, A. ARUFFO, N. K. DAMLE & J. A. LEDBETTER. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin-2 mRNA accumulation. J. Exp. Med. 173: 721-730.
13. LINSLEY, P. S., W. BRADY, M. URNES, L. S. GROSMAIRE, N. K. DAMLE & J. A. LEDBETTER. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174: 561-570.
14. HATHCOCK, K. S., G. LASZLO, C. PUCILLO, P. LINSLEY & R. J. HODES. 1994. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 180: 631-640.
15. LENSCHOW, D. J., A. I. SPERLING, M. P. COOKE, G. FREEMAN, L. RHEE, D. C. DECKER, G. GRAY, L. M. NADLER, C. C. GOODNOW & J. A. BLUESTONE. 1994. Differential upregulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. J. Immunol. 153: 1990-1997.
16. CHEN, C., A. GAULT, L. SHEN & N. NABAVI. 1994. Molecular cloning and expression of early T cell costimulatory molecule-1 and its characterization as B7-2 molecule. J. Immunol. 152: 4929-4936.
17. + T lymphocytes. J. Immunol. 151: 2368-2379.
18. FREEMAN, G. J., V. A. BOUSSIOTIS, A. ANUMANTHAN, G. M. BERNSTEIN, X-Y. KE, P. D. RENNERT, G. S. GRAY, J. G. GRIBBEN & L. M. NADLER. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2: 523-532.
19. KUCHROO, V. K., M. P. DAS, J. A. BROWN, A. M. RANGER, S. S. ZAMVIL, R. A. SOBEL, H. L. WEINER, N. NABAVI & L. H. GLIMCHER. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80: 707-718.
20. THOMPSON, C. B. 1995. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 81: 979-982.
21. SCHILD, H., O. ROTZSCHKE, H. KALBACHER & H. G. RAMMENSEE. 1990. Limit of T cell tolerance to self proteins by peptide presentation. Science 247: 1587-1589.
22. GAMMON, G., E. E. SERCARZ & G. BENICHOU. 1991. The dominant self and the cryptic self: shaping the autoreactive T-cell repertoire. Immunol. Today 12: 193-195.
23. MAMULA, M. J. 1993. The inability to process a self-peptide allows autoreactive T cells to escape tolerance. J. Exp. Med. 177: 567-571.
24. LEHMANN, P. V., T. FORSTHUBER, A. MILLER & E. E. SERCARZ. 1992. Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature 358: 155-157.
25. SERCARZ, E. E., P. V. LEHMANN, A. AMETANI, G. BENICHOU, A. MILLER & K. MOUDGIL. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11: 729-766.
26. MARKOVIC-PLESE, S., H. FUKAURA, J. ZHANG, A. AL-SABBAGH, S. SOUTHWOOD, A. SETTE, V. K. KUCHROO & D. A. HAFLER. 1995. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J. Immunol. 155: 982-992.
27. LIN, R-H., M. J. MAMULA, J. A. HARDIN & C. A. JANEWAY, JR. 1991. Induction of autoreactive B cells allows priming of autoreactive T cells. J. Exp. Med. 173: 1433-1439.
28. MAMULA, M. J., R-H. LIN, C. A. JANEWAY, JR. & J. A. HARDIN. 1992. Breaking T cell tolerance with foreign and self co-immunogens: a study of autoimmune B and T cell epitopes of cytochrome c. J. Immunol. 149: 789-795.
29. MAMULA, M. J., S. FATENEJAD & J. CRAFT. 1994. B cells process and present lupus autoantigens that initiate autoimmune T cell responses. J. Immunol. 152: 1453-1461.
30. LUTZ-FREYERMUTH, C., C. C. QUERY & J. KEENE. 1990. Quantitative determination that one of the two potential RNA-binding domains of the A protein component of the U1 small nuclear ribonucleoprotein complex binds with high affinity to stem-loop II of U1 RNA. Proc. Natl. Acad. Sci. U.S.A. 87: 693-697.
31. KITAMURA, D., J. ROES, R. KUHN & K. RAJEWSKY. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350: 423-426.
32. CHEN, C. & N. NABAVI. 1994. In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2. Immunity 1: 147-154.
33. NABAVI, N., G. J. FREEMAN, A. GAULT, D. GODFREY, L. M. NADLER & L. H. GLIMCHER. 1992. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 360: 266-268.
34. + T cells. J. Immunol. 154: 4915-4923.
35. TAKANO, T. & R. E. DICKERSON. 1981. Conformational change of cytochrome c. I. Ferrocytochrome c structure refined at 1.5-angstrom resolution. J. Mol. Biol. 153: 79-94.
36. ANDREWS, B. S., R. A. EISENBERG, A. N. THEOFILOPOULOS, S. IzuI, C. B. WILSON, P. J. MCCONAHEY, E. D. MURPHY, J. B. ROTHS & F. J. DIXON. 1978. Spontaneous murine lupus-like syndromes: clinical and immunopathological manifestations in several strains. J. Exp. Med. 148: 1198-1215.
37. EISENBERG, R. A., E. M. TAN & F. J. DIXON. 1978. Presence of anti-Sm reactivity in autoimmune mouse strains. J. Exp. Med. 147: 582-587.
38. FINK, B. K., P. S. LINSLEY & D. WOFSY. 1994. Treatment of murine lupus with CTLA4Ig. Science 265: 1225-1227.
39. MAMULA, M. J. & C. A. JANEWAY, JR. 1993. Do B cells drive the diversification of immune responses? Immunol. Today 14: 151-152.
40. ROCK, K. L., B. BENACERRAF & A. K. ABBAS. 1984. Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. J. Exp. Med. 160: 1102-1113.
41. LANZAVECCHIA, A. 1985. Antigen-specific interactions between T and B cells. Nature 314: 537-539.
42. LANZAVECCHIA, A. 1990. Receptor-mediated antigen uptake and its effect on antigen presentation to class H-restricted T lymphocytes. Annu. Rev. Immunol. 8: 773-793.
43. EYNON, E. E. & D. C. PARKER. 1992. Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 175: 131-138.
44. FUCHS, E. J. & P. MATZINGER. 1992. B cells turn off virgin, but not memory T cells. Science 258: 1156-1159.
45. GILBERT, K. M. & W. O. WEIGLE. 1994. Tolerogenicity of resting and activated B cells. J. Exp. Med. 179: 249-258.
46. RONCHESE, F. & B. HAUSMANN. 1993. B lymphocytes in vivo fail to prime naive T cells, but can stimulate antigen-experienced T lymphocytes. J. Exp. Med. 177: 679-690.
47. + T cells. J. Exp. Med. 179: 1539-1549.
48. + T cells in vitro: characteristics and antigen-presenting cell requirements. J. Exp. Med. 176: 1431-1437.
49. CROFT, M., L. M. BRADLEY & S. L. SWAIN. 1994. Naive versus memory CD4 T cell response to antigen: memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J. Immunol. 152: 2675-2685.
50. CASSELL, D. J. & R. H. SCHWARTZ. 1994. A quantitative analysis of antigen-presenting cell function: activated B cells stimulate naive CD4 T cells, but are inferior to dendritic cells in providing costimulation. J. Exp. Med. 180: 1829-1840.
51. METLAY, J. P., E. PURE & R. M. STEINMAN. 1989. Control of the immune response at the level of antigen-presenting cells: a comparison of the function of dendritic cells and B lymphocytes. Adv. Immunol. 47: 45-116.
52. LINSLEY, P. S., P. M. WALLACE, J. JOHNSON, M. G. GIBSON, J. L. GREENE, J. A. LEDBETTER, C. SlNGH & M. A. TEPPER. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257: 792-795.
53. LINSLEY, P. S., J. L. GREENE, P. TAN, J. BRADSHAW, J. A. LEDBETTER, C. ANASETTI & N. K. DAMLE. 1992. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176: 1595-1604.
54. FREEMAN, G. J., A. S. FREEDMAN, J. M. SEGIL, G. LEE, J. F. WHITMAN & L. M. NADLER. 1989. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143: 2714-2722.
55. DAVIDSON, H. W. & C. WATTS. 1989. Epitope directed processing of specific antigen by B lymphocytes. J. Cell Biol. 109: 85-92.
56. WATTS, C. &A. LANZAVECCHIA. 1993. Suppressive effect of antibody on processing of T cell epitopes. J. Exp. Med. 178: 1459-1463.
57. MAMULA, M. J. 1995. Lupus autoimmunity: from peptides to particles. Immunol. Rev. 144: 301-314.
58. MAMULA, M. J. &J. CRAFT. 1994. Expression of self antigenic determinants: implications for tolerance and autoimmunity. Curr. Opin. Immunol. 6: 882-886.